Angiogenesis and cancer metastasis: antiangiogenic therapy of human pancreatic adenocarcinoma.
Baker
C H
CH
Department of Cancer Biology-173, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Solorzano
C C
CC
Fidler
I J
IJ
D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D002277:Carcinoma / Q000473:pathology*; D016228:Endothelial Growth Factors / Q000096:biosynthesis / Q000494:pharmacology; D006801:Humans; D008222:Lymphokines / Q000096:biosynthesis / Q000494:pharmacology; D009362:Neoplasm Metastasis / Q000503:physiopathology*; D009360:Neoplastic Cells, Circulating; D009389:Neovascularization, Pathologic; D010190:Pancreatic Neoplasms / Q000473:pathology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors